Back to Search
Start Over
Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward.
- Source :
-
Infection and drug resistance [Infect Drug Resist] 2021 May 18; Vol. 14, pp. 1845-1853. Date of Electronic Publication: 2021 May 18 (Print Publication: 2021). - Publication Year :
- 2021
-
Abstract
- Purpose: The cost-effectiveness of different guideline-concordant antimicrobial regimens for elderly patients with community-acquired pneumonia (CAP) was rarely discussed. This study attempts to explore the most appropriate cost-effectiveness of guideline-concordant antimicrobial regimen for elderly patients with CAP in general wards.<br />Patients and Methods: This was a multicenter, retrospective, 4:2:1 matched study enrolling 511 elderly patients with CAP hospitalized in general wards. Two hundred ninety-two patients prescribed with β-lactam monotherapy (group A), 146 patients prescribed with fluoroquinolone monotherapy (group B) and 73 patients prescribed with β-lactam/macrolide combination therapy (group C). Clinical outcomes and medical costs were analyzed by χ <superscript>2</superscript> test for categorical variables or Kruskal-Wallis H -test for continuous variables.<br />Results: There were no statistical differences in imaging features, etiology and complications during hospitalization among these three groups. The rates of clinical failure occurrence, in-hospital mortality, 30-day mortality and 60-day mortality also had no significant differences among group A, B and C patients; however, the median length of stay (LOS) in group A patients was 12.0 days, which was significantly higher than that in group B and C patients (both 10.0 days, p<0.02). The median total, drug, and antibiotic costs for one elderly CAP episode in group B patients were RMB 10368.4, RMB 3874.8, and RMB 1796.3, respectively, which were significantly lower than those in group A and C patients (p<0.01).<br />Conclusion: Non-inferiority of clinical failure occurrence and short-term mortality was observed in different guideline-concordant antimicrobial regimens for elderly patients with CAP in general wards; however, the median LOS and hospitalization-associated costs for one elderly CAP episode with fluoroquinolone monotherapy were significantly lowest, and this strategy was considered to be the most cost-effective strategy in general wards.<br />Competing Interests: The authors report no conflicts of interest in this work.<br /> (© 2021 Han et al.)
Details
- Language :
- English
- ISSN :
- 1178-6973
- Volume :
- 14
- Database :
- MEDLINE
- Journal :
- Infection and drug resistance
- Publication Type :
- Academic Journal
- Accession number :
- 34040398
- Full Text :
- https://doi.org/10.2147/IDR.S302852